AD
Recursion logo

Recursion

🇺🇸

AI-Powered Drug Discovery Platform

80

Overall score

0

Heat score

Pricing

No pricing plans published yet.

Technical Specs

Inputs

Biological Data, Chemical Structures, Text Prompt

Outputs

Molecule Designs, Predictive Models, Drug Candidates

AI Type

Generative AI

Model Architecture

N/A

Daily Prompts

N/A

Context Length

N/A

Output Quality

Accuracy

80%

Content

80%

Reasoning

80%

Company Profile

Company

Recursion Pharmaceuticals

Founded

2014

HQ

Salt Lake City, Utah

Employees

N/A

Total Raised / Total Funding

N/A

Revenue

N/A

Valuation

N/A

ARR

N/A

CEO

Najat Khan

Overview

Estimated Paid Users

N/A

Current estimate

Total Earnings Till Date

N/A

No monthly delta yet

Market Share

N/A

Current share

Average Session

N/A

Per active user

Hallucination Rate

80%

Model quality signal

Growth Rate

N/A

Monthly active users

Burn Rate

N/A

Total expenses / years active

Paid User Gain

N/A

Monthly paid user trend

No demo video available yet.

Platforms

AD

Performance Metrics

Accuracy

80%

Context

80%

Reasoning

80%

Safety

80%

Benchmarks

No benchmark scores available.

Recursion Models

No model/version data available.

Funding Rounds & Investors

Total Funding

N/A

Rounds

1

Other

N/A

Jun 2021

Source: Crunchbase

Founders/Team

CG

Chris Gibson

Co-Founder, CEO

NK

Najat Khan

Co-Founder, Chair

Direct competitors

No direct competitors available.

Change Log / Major Updates

No changelog entries available.

Compliance, Integrations & Support

Industry: Healthcare

Compliances: Not specified

Integrations: WordPress, Zapier

Support:email, help center

Target audience: Drug Researchers, Pharmaceutical Companies, Biotech Scientists, Medical Researchers, AI Model Developers

Supported languages: English

Recursion Acquisitions

No acquisition records available.

AD

Reviews & Rating

0 reviews

No reviews yet

Be the first to share how Recursion performs for your workflow.

0.0

Accuracy

0.0

Ease of Use

0.0

Output Quality

0.0

Security

0.0

More About Recursion

Founded in 2014 by Chris Gibson, Recursion AI leverages sophisticated machine learning algorithms to transform drug discovery. By analyzing vast datasets of biological and chemical relationships, the platform accelerates the identification of potential drug candidates and optimizes development processes.

Key capabilities include intelligent model training for rapid target identification and molecule design, supported by integrations with tools like WordPress and Zapier.

With a commitment to decoding biology, Recursion has established partnerships with major pharma companies, demonstrating the power of AI in creating novel medicines for complex diseases.

Recursion FAQ's

No FAQs available.